Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity.

類似資料

• m17-1A-, c17-1A- and cSF25-mediated antibody-dependent cell-mediated cytotoxicity in patients with advanced cancer.
  著者:: Pullyblank, A. M., 等
  出版事項: (1994)
• Faecal interleukin-8 and tumour necrosis factor-alpha concentrations in cystic fibrosis.
  著者:: Briars, G L, 等
  出版事項: (1995)
• Lipopolysaccharide synergizes with tumour necrosis factor-alpha in cytotoxicity assays.
  著者:: Pfister, H, 等
  出版事項: (1992)
• Anti-tumour necrosis factor alpha treatment in patients affected by rheumatoid arthritis with anti-Ro/SSA antibodies
  著者:: Cavazzana, I, 等
  出版事項: (2005)
• The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection.
  著者:: Yerkovich, S T, 等
  出版事項: (1997)